Global Prostate Cancer Drugs Market 2016-2020

Table of Contents

PART 01: Executive summary

• Highlights

PART 02: Scope of the report

• Market overview
• Top-vendor offerings

PART 03: Market research methodology

• Research methodology
• Economic indicators

PART 04: Introduction

• Key market highlights

PART 05: Disease overview

• Understanding disease
• Types of prostate cancer
• Diagnosis
• Key buying criteria

PART 06: Pipeline analysis

PART 07: Market landscape

• Global prostate cancer therapeutics market
• Five forces analysis

PART 08: Market segmentation by therapy

• Hormonal therapy
• Chemotherapy
• Immunotherapy
• Targeted therapy

PART 09: Geographical segmentation

• Global prostate cancer drugs market by geographical segmentation 2015-2020
• Prostate cancer drugs market in Americas
• Prostate cancer drugs market in EMEA
• Prostate cancer drugs market in APAC

PART 10: Market drivers

• Physicians preference toward adopting hormonal therapies
• Development of drugs with novel mechanism of action
• Availability of large patient pool

PART 11: Impact of drivers

PART 12: Market challenges

• Presence of alternative treatment approaches
• High cost of drugs
• Adverse side-effects of drugs

PART 13: Impact of drivers and challenges

PART 14: Market trends

PART 15: Vendor landscape

• Competitive scenario

PART 16: Key vendor analysis

Johnson & Johnson

• Astellas Pharma
• AstraZeneca
• Sanofi
• AbbVie
• Other prominent vendors

PART 17: Appendix

• List of abbreviations

PART 18: Explore Technavio